Brief: Tivic Health Systems FY Net Income USD -8.244 Million
25/03/2024 21:25
Mar 25 (Reuters) - Tivic Health Systems FY revenue USD 1.176 million. * FY basic EPS USD -10.4 * FY operating expenses USD 8.532 million * FY gross profit USD 287 thousand * FY operating income USD -8.245 million
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital